[1] Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol, 2009, 10:857-863. [2] Trifari S, Kaplan CD, Tran EH, et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1and T(H)2 cells. Nat Immunol, 2009, 10:864-871. [3] Eyerich Stefanie , Eyerich Kilian, Pennino Davide，et al.Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. Journal of Clinical Investigation, 2009, 19:3573-3585. [4 ] Sa S M，Valdez P A，Wu J et al．The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol, 2007, 178: 2229-2240. [5] Wolk K，Witte E，Wallace E et al．IL-22 regulates the expression of genes responsible for antimicrobial defense，cellular differentation，and mobility in keratinocytes：a potential role in psoriasis．Eur J Imnmnol, 2006, 36: 1309-1323. [6] 侯卫坤,周艳,吕社民.Th22型细胞与炎症性疾病的关系.细胞与分子免疫学杂志,2010,26:89-90. [7] 李炫昊，杜林栋.白细胞介素-22对细胞信号转导通路的影响.国际外科学杂志,2009,36:849－852. [8] 庄园,石云,邹全明. IL-22：Thl7细胞的重要效应分子.中国免疫学杂志，2009,25:761-7649. [9] Andoh A, Zhang Z, Inatomi O, et al . Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology, 2005, 129: 969-984. [10] Ikeuchi H, Kuroiwa T, Hiramatsu N, et al. Expression of interleukin-22 in rheumatoid arthritis-potential role as a proinflammatory cytokine.Arthritis Rheum, 2005, 52: 1037-1046. [11] Boniface K，Bernard FX，Garcia M，el al．IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol, 2005, 174: 3695-3702. [12] Zheng Y，Danflenko DM，Valdez P，et al．Interleukin-22，a T(H)17 cytokine，mediates IL-23-induced dermal inflammation and aeanthesia．Nature, 2007, 445: 648-651. [13] Yeh J H，Sidhu S S，Olan A C，et al. Regulation of a lated phase of T cell polarity and effector functions by Crtam．Cell, 2008, 132: 846-859. [14] Kagami S, Rizzo HL, Lee JJ, et al. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol, 2010, 130: 1373-83. [15 ] Wolk K, Witte E, Warszawska K, et al. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur J Immunol, 2009, 39: 3570–3581. [16] Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum, 2009, 60:1647–1656. [17] Geboes L，Dumoutier L，Kelchtermans H，et al.Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice．Arthritis Rheum,2009, 60: 390-395. [18] Brand S, Beigel F, Olszak T, et al.IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol, 2006, 290: 827–838. [19 ] Wolk K, Witte E, Hoffmann U, et al.IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn’s disease. J Immunol, 2007, 178: 5973–5981. [20] Schmechel S, Konrad A, Diegelmann J, et al. Linking genetic susceptibility to Crohn’s disease with Th17 cell function: IL-22 serum levels are increased in Crohn’s disease and correlate with disease activity and IL-23R Genotype status. Infamm Bowel Dis, 2008, 14: 204-212. [21] Sugimoto K, Ogawa A, Mizoguchi E. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest, 2008, 118: 534-544. [22] Kebir H，Kreymbor8 K, Ifergan I, et al．Human THl7 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation．Nat Med, 2007, 13: 1173-1175. [23] Chang H, Hanawa H, Liu H, et al．Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol, 2006, 177: 3635–3643. [24] Pan HF，Zhan XF，Yuan H，et al．Decrease serum IL-22 levels in patients with systemic lupus erythematous．Clin Chim Aeta, 2009，401: 179-180. [25] Ma H L, Liang S, Li J .IL-22 is required for TH17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. Clin Invest, 2008, 118: 597-607. [26] Bard JD, Gelebart P, Anand M, et al. Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia, 2008, 22: 1595–1603. [27] Zhang W, Chen Y, Wei H, et al. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res, 2008, 14: 6432–6439.